IQVIA Holdings Inc.

NYSE:IQV

Medical - Diagnostics & Research

Healthcare
$257.84 -1.83%

-$3.13 today

Market cap
$42.49B
Beta
1.22
P/E (TTM)
20.4
EPS (TTM)
$8.22
52W Low $153.01High $247.05

Volume 1.40M

Average 1.62M

IQV Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

IQVIA Holdings Inc.NYSE: IQV

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue grows, but more slowly than its trailing trend

Q2 FY2026 cost of revenue of $2.93B rose 8.9% year over year, behind the +21.4% change in trailing-twelve-month cost of revenue. Sequentially, it rose 4.9% from the prior quarter. Over 3 fiscal years it compounded at +5.1% a year.

Context

  • Cost of revenue amounted to 66.7% of revenue in FY2025, up 1.6 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +8.9% toward the trailing-twelve-month pace of +21.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$2.93B+4.9% QoQ
Last fiscal yearDec 2025
$10.88B+8.5% YoY
LTMJun 2026
$12.53B+21.4% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.9%——
1 year+8.5%——
3-year CAGR+5.1%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
10.88B USD
Year-over-year change
+8.5%
4-year CAGR
+4.2%

Cost of Revenue vs competitors

How IQV compares with its peers on the latest reported figures

  • IQV's LTM Jun 2026 cost of revenue of $12.53B is the highest of the 9 companies compared; the peer median is $1.44B.
  • Its year-over-year change of +21.4% is the 2nd highest of 9, against a peer median of +11.9%.
  • Cost of revenue amounts to 73.8% of revenue for IQV, versus a peer median of 60.9%.
IQV Competitors Peer median
Cost of Revenue for IQV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IQVIQVIA Holdings Inc.LTM Jun 2026$12.53B +21.4%+5.1%73.8%
ICLRICON Public Limited CompanyLTM Jun 2026$6.45B +11.6%+3.2%78.2%
CRLCharles River Laboratories International, Inc.LTM Jun 2026$2.71B -0.4%+3.5%67.8%
FTREFortrea Holdings Inc.LTM Jun 2026$2.22B +0.2%+2.8%82.9%
MEDPMedpace Holdings, Inc.LTM Sep 2026$2.01B +23.8%+19.9%70.9%
VEEVVeeva Systems Inc.LTM Jul 2026$868.21M +19.8%+8.7%25.1%
TEMTempus AI, Inc.LTM Sep 2026$505.6M +19.5%+35.5%33.5%
CERTCertara, Inc.LTM Mar 2026$175.81M +12.1%+6.7%41.9%
HCATHealth Catalyst, Inc.LTM Mar 2026$163.38M -4.2%+13.1%54.0%
Peer median (excluding IQV) $1.44B+11.9%+7.7%60.9%

Competitors are the stored peer set for IQV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue13.87B14.41B14.98B15.41B16.31B
Cost of Revenue9.23B9.38B9.75B10.03B10.88B
Gross Profit4.64B5.03B5.24B5.38B5.43B
Gross Margin33.5%34.9%35.0%34.9%33.3%
Research & Development00000
Selling, General & Admin1.96B2.07B2.05B1.99B1.99B
Operating Expenses3.25B3.23B3.26B3.17B3.25B
Depreciation & Amortization1.26B1.13B1.13B1.11B640M
EBITDA2.77B2.91B3.26B3.45B2.94B
EBITDA Margin19.9%20.2%21.7%22.4%18.0%
Operating Income1.39B1.8B1.98B2.2B2.18B
Operating Margin10.0%12.5%13.2%14.3%13.4%
Interest Income6M13M36M47M45M
Interest Expense375M416M672M670M729M
Other Income / Expenses(259M)(448M)(518M)(533M)(569M)
Income Before Tax1.13B1.35B1.46B1.67B1.61B
Pre-Tax Margin8.2%9.4%9.7%10.8%9.9%
Income Tax Expense163M260M101M296M252M
Net Income966M1.09B1.36B1.37B1.36B
Net Margin7.0%7.6%9.1%8.9%8.3%
EPS (Basic)5.055.827.397.577.91
EPS (Diluted)4.955.727.297.497.84
Weighted Avg Shares191.4M187.6M183.8M181.3M171.9M
Weighted Avg Shares (Diluted)195M190.6M186.3M183.4M173.5M

IQVIA Holdings Inc.

NYSE:IQV

Intrinsic Alpha fair value

Locked

Current Price

$257.84

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.